Para MF - Search Results

1

Pharmacokinetic interaction between efavirenz and dual protease inhibitors in healthy volunteers.

Ma Q, Forrest A, Rosenkranz SL, Para MF, Yarasheski KE, Reichman RC, Morse GD; ACTG A5043 Protocol Team, DAIDS, NIH. Ma Q, et al. Among authors: para mf. Biopharm Drug Dispos. 2008 Mar;29(2):91-101. doi: 10.1002/bdd.597. Biopharm Drug Dispos. 2008. PMID: 18041735 Free PMC article. Clinical Trial.

2

Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.

Morse GD, Rosenkranz S, Para MF, Segal Y, Difrancesco R, Adams E, Brizz B, Yarasheski KE, Reichman RC. Morse GD, et al. Among authors: para mf. Antimicrob Agents Chemother. 2005 Aug;49(8):3373-81. doi: 10.1128/AAC.49.8.3373-3381.2005. Antimicrob Agents Chemother. 2005. PMID: 16048950 Free PMC article. Clinical Trial.

3

Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.

Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD; ACTG 5043 Protocol Team. Okusanya O, et al. Among authors: para mf. Antimicrob Agents Chemother. 2007 May;51(5):1822-6. doi: 10.1128/AAC.00570-06. Epub 2007 Feb 5. Antimicrob Agents Chemother. 2007. PMID: 17283195 Free PMC article.

4

Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.

Smith PF, Dicenzo R, Forrest A, Shelton M, Friedland G, Para M, Pollard R, Fischl M, DiFrancesco R, Morse GD. Smith PF, et al. Clin Pharmacokinet. 2005;44(1):99-109. doi: 10.2165/00003088-200544010-00004. Clin Pharmacokinet. 2005. PMID: 15634033 Clinical Trial.

5

Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teams.

Morse GD, Reichman RC, Fischl MA, Para M, Leedom J, Powderly W, Demeter LM, Resnick L, Bassiakos Y, Timpone J, Cox S, Batts D. Morse GD, et al. Antiviral Res. 2000 Jan;45(1):47-58. doi: 10.1016/s0166-3542(99)00073-x. Antiviral Res. 2000. PMID: 10774589 Clinical Trial.

6

Antiretroviral Drug Levels and Interactions Affect Lipid, Lipoprotein, and Glucose Metabolism in HIV-1 Seronegative Subjects: A Pharmacokinetic-Pharmacodynamic Analysis.

Rosenkranz SL, Yarasheski KE, Para MF, Reichman RC, Morse GD. Rosenkranz SL, et al. Among authors: para mf. Metab Syndr Relat Disord. 2007 Jun;5(2):163-73. doi: 10.1089/met.2006.0034. Metab Syndr Relat Disord. 2007. PMID: 18007962 Free PMC article.

7

Phase I study of atevirdine, a nonnucleoside reverse transcriptase inhibitor, in combination with zidovudine for human immunodeficiency virus type 1 infection. ACTG 199 Study Team.

Reichman RC, Morse GD, Demeter LM, Resnick L, Bassiakos Y, Fischl M, Para M, Powderly W, Leedom J, Greisberger C, et al. Reichman RC, et al. J Infect Dis. 1995 Feb;171(2):297-304. doi: 10.1093/infdis/171.2.297. J Infect Dis. 1995. PMID: 7531207 Clinical Trial.

8

Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.

Collier AC, Tierney C, Downey GF, Eshleman SH, Kashuba A, Klingman K, Vergis EN, Pakes GE, Rooney JF, Rinehart A, Mellors JW; AIDS Clinical Trials Group Protocol A5143 Team. Collier AC, et al. HIV Clin Trials. 2008 Mar-Apr;9(2):91-102. doi: 10.1310/hct0902-91. HIV Clin Trials. 2008. PMID: 18474494 Clinical Trial.

9

Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.

Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertora J, Patterson KB, Daar ES, Cavert W, Brizz B; ACTG A5200 Team of the ACTG. Para MF, et al. J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):491-5. doi: 10.1097/QAI.0b013e3181d142cb. J Acquir Immune Defic Syndr. 2010. PMID: 20130470 Free PMC article. Clinical Trial.

10

A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen.

Hammer SM, Ribaudo H, Bassett R, Mellors JW, Demeter LM, Coombs RW, Currier J, Morse GD, Gerber JG, Martinez AI, Spreen W, Fischl MA, Squires KE; AIDS Clinical Trials Group (ACTG) 372A Study Team. Hammer SM, et al. HIV Clin Trials. 2010 Nov-Dec;11(6):312-24. doi: 10.1310/hct1106-312. HIV Clin Trials. 2010. PMID: 21239359 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters